![]() |
Name |
Altertoxin I
|
Molecular Formula | C20H16O6 | |
IUPAC Name* |
(12S,12aS,12bR)-4,9,12,12b-tetrahydroxy-2,11,12,12a-tetrahydro-1H-perylene-3,10-dione
|
|
SMILES |
C1C[C@]2([C@@H]3[C@H](CC(=O)C4=C(C=CC(=C34)C5=C2C(=C(C=C5)O)C1=O)O)O)O
|
|
InChI |
InChI=1S/C20H16O6/c21-10-3-1-8-9-2-4-11(22)17-12(23)5-6-20(26,18(9)17)19-14(25)7-13(24)16(10)15(8)19/h1-4,14,19,21-22,25-26H,5-7H2/t14-,19+,20-/m0/s1
|
|
InChIKey |
GJIALGLHOBXNAT-KPOBHBOGSA-N
|
|
Synonyms |
Altertoxin I; 56258-32-3; Altertoxin l; (12S,12aS,12bR)-4,9,12,12b-tetrahydroxy-2,11,12,12a-tetrahydro-1H-perylene-3,10-dione; Altertoxin-I; altertoxin-1; CCRIS 2190; 3,10-Perylenedione, 1,2,11,12,12a,12b-hexahydro-1,4,9,12a-tetrahydroxy-, (1S,12aR,12bS)-; CHEMBL521470; SCHEMBL22837286; DTXSID40971689; HY-N6724; ZINC6092274; 1,2,7,8,12b-pentahydro-1,4,6b,10-tetrahydroxyperylene-3,9-dione; BDBM50479261; BA162708; Altertoxin I 10 microg/mL in Acetonitrile; CS-0085164; 1,4,9,12a-Tetrahydroxy-1,2,11,12,12a,12b-hexahydroperylene-3,10-dione
|
|
CAS | 56258-32-3 | |
PubChem CID | 104860 | |
ChEMBL ID | CHEMBL521470 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 352.3 | ALogp: | 1.4 |
HBD: | 4 | HBA: | 6 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 115.0 | Aromatic Rings: | 5 |
Heavy Atoms: | 26 | QED Weighted: | 0.579 |
Caco-2 Permeability: | -5.438 | MDCK Permeability: | 0.00000943 |
Pgp-inhibitor: | 0.016 | Pgp-substrate: | 0.181 |
Human Intestinal Absorption (HIA): | 0.787 | 20% Bioavailability (F20%): | 0.983 |
30% Bioavailability (F30%): | 0.998 |
Blood-Brain-Barrier Penetration (BBB): | 0.081 | Plasma Protein Binding (PPB): | 89.04% |
Volume Distribution (VD): | 1.156 | Fu: | 8.25% |
CYP1A2-inhibitor: | 0.438 | CYP1A2-substrate: | 0.13 |
CYP2C19-inhibitor: | 0.154 | CYP2C19-substrate: | 0.058 |
CYP2C9-inhibitor: | 0.536 | CYP2C9-substrate: | 0.771 |
CYP2D6-inhibitor: | 0.501 | CYP2D6-substrate: | 0.225 |
CYP3A4-inhibitor: | 0.549 | CYP3A4-substrate: | 0.165 |
Clearance (CL): | 1.957 | Half-life (T1/2): | 0.098 |
hERG Blockers: | 0.081 | Human Hepatotoxicity (H-HT): | 0.183 |
Drug-inuced Liver Injury (DILI): | 0.613 | AMES Toxicity: | 0.845 |
Rat Oral Acute Toxicity: | 0.26 | Maximum Recommended Daily Dose: | 0.124 |
Skin Sensitization: | 0.666 | Carcinogencity: | 0.63 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.1 |
Respiratory Toxicity: | 0.097 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005389 | ![]() |
1.000 | D0H6QU | ![]() |
0.303 | ||
ENC003652 | ![]() |
0.738 | D01XDL | ![]() |
0.298 | ||
ENC005311 | ![]() |
0.738 | D0R9WP | ![]() |
0.289 | ||
ENC003252 | ![]() |
0.738 | D0R3JB | ![]() |
0.286 | ||
ENC000841 | ![]() |
0.726 | D08LTU | ![]() |
0.282 | ||
ENC002281 | ![]() |
0.714 | D07MGA | ![]() |
0.279 | ||
ENC000881 | ![]() |
0.694 | D0H1AR | ![]() |
0.279 | ||
ENC003841 | ![]() |
0.648 | D07JHH | ![]() |
0.274 | ||
ENC000987 | ![]() |
0.516 | D0R6RC | ![]() |
0.274 | ||
ENC005474 | ![]() |
0.516 | D01XWG | ![]() |
0.268 |